CLEC1B and gastric cancer: Wang et al. have put forward that CLEC2 inhibits gastric cancer metastasis, prevents the activation of AKT and glycogen synthase signals, and affects the invasion and expression of EMT markers, which can be a potential biomarker in gastric cancer [42].